Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick-Pascal Strunz

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Zeitschrift Fur Rheumatologie|May 10, 2023
[This is how I treat patients who need DMARD treatment and have MGUS]Patrick-Pascal Strunz, Marc Schmalzing
Zeitschrift Fur Rheumatologie|January 23, 2023
[Paraneoplastic syndromes in rheumatology]Patrick-Pascal Strunz, Marc Schmalzing
Zeitschrift Fur Rheumatologie|June 19, 2026
[Update: DMARDs for MGUS]Patrick-Pascal Strunz, Marc Schmalzing
Deutsche Medizinische Wochenschrift (1946)|September 23, 2021
[26-year-old man presenting with nail alterations]Benjamin Krichevsky, Patrick-Pascal Strunz, Johannes Heck
Zeitschrift Fur Rheumatologie|October 10, 2025
[Digital health applications and axial spondyloarthritis]Patrick-Pascal Strunz, Uta Kiltz, David Kiefer, et al.
Dermatologie (Heidelberg, Germany)|September 1, 2025
[Lupus erythematosus]Patrick-Pascal Strunz, Marc Schmalzing, Matthias Goebeler, et al.
Therapeutic Advances in Musculoskeletal Disease|December 2, 2025
Clinical and immunological long-term outcomes after autologous hematopoietic stem cell transplantation in systemic sclerosis: a retrospective single-center experienceMichael Gernert, Jörg Henes, Patrick-Pascal Strunz, et al.
Frontiers in Immunology|March 26, 2026
Case Report: Switching secukinumab to bimekizumab in diffuse cutaneous systemic sclerosis after autologous hematopoietic stem cell transplantation: a case follow-upLea-Kristin Nagler, Patrick-Pascal Strunz, Hannah Labinsky, et al.
Leukemia & Lymphoma|July 19, 2019
Response to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donorPatrick-Pascal Strunz, Marc Schmalzing, Anke Heidemeier, et al.
Arthritis Research & Therapy|August 19, 2022
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapyMichael Gernert, Marc Schmalzing, Hans-Peter Tony, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Zeitschrift Fur Rheumatologie|May 10, 2023
[This is how I treat patients who need DMARD treatment and have MGUS]Patrick-Pascal Strunz, Marc Schmalzing
Zeitschrift Fur Rheumatologie|January 23, 2023
[Paraneoplastic syndromes in rheumatology]Patrick-Pascal Strunz, Marc Schmalzing
Zeitschrift Fur Rheumatologie|June 19, 2026
[Update: DMARDs for MGUS]Patrick-Pascal Strunz, Marc Schmalzing
Deutsche Medizinische Wochenschrift (1946)|September 23, 2021
[26-year-old man presenting with nail alterations]Benjamin Krichevsky, Patrick-Pascal Strunz, Johannes Heck
Zeitschrift Fur Rheumatologie|October 10, 2025
[Digital health applications and axial spondyloarthritis]Patrick-Pascal Strunz, Uta Kiltz, David Kiefer, et al.
Dermatologie (Heidelberg, Germany)|September 1, 2025
[Lupus erythematosus]Patrick-Pascal Strunz, Marc Schmalzing, Matthias Goebeler, et al.
Therapeutic Advances in Musculoskeletal Disease|December 2, 2025
Clinical and immunological long-term outcomes after autologous hematopoietic stem cell transplantation in systemic sclerosis: a retrospective single-center experienceMichael Gernert, Jörg Henes, Patrick-Pascal Strunz, et al.
Frontiers in Immunology|March 26, 2026
Case Report: Switching secukinumab to bimekizumab in diffuse cutaneous systemic sclerosis after autologous hematopoietic stem cell transplantation: a case follow-upLea-Kristin Nagler, Patrick-Pascal Strunz, Hannah Labinsky, et al.
Leukemia & Lymphoma|July 19, 2019
Response to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donorPatrick-Pascal Strunz, Marc Schmalzing, Anke Heidemeier, et al.
Arthritis Research & Therapy|August 19, 2022
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapyMichael Gernert, Marc Schmalzing, Hans-Peter Tony, et al.
Pageof 5